A detailed history of Geneos Wealth Management Inc. transactions in Schrodinger, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 59,996 shares of SDGR stock, worth $1.28 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
59,996
Previous 51,975 15.43%
Holding current value
$1.28 Million
Previous $964,000 20.02%
% of portfolio
0.04%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

BUY
$16.98 - $22.57 $136,196 - $181,033
8,021 Added 15.43%
59,996 $1.16 Million
Q3 2024

Nov 14, 2024

BUY
$18.05 - $24.02 $50,919 - $67,760
2,821 Added 5.74%
51,975 $964,000
Q2 2024

Jul 23, 2024

BUY
$18.65 - $28.5 $224,322 - $342,798
12,028 Added 32.4%
49,154 $950,000
Q1 2024

May 03, 2024

BUY
$24.74 - $35.13 $378,769 - $537,840
15,310 Added 70.18%
37,126 $1 Million
Q4 2023

Jan 26, 2024

BUY
$21.62 - $37.21 $278,898 - $480,009
12,900 Added 144.68%
21,816 $781,000
Q3 2023

Oct 11, 2023

BUY
$27.34 - $55.37 $242,177 - $490,467
8,858 Added 15272.41%
8,916 $252,000
Q2 2023

Aug 08, 2023

BUY
$26.1 - $49.92 $208 - $399
8 Added 16.0%
58 $2,000
Q1 2023

Apr 25, 2023

SELL
$18.09 - $27.61 $144 - $220
-8 Reduced 13.79%
50 $1,000
Q3 2021

Nov 09, 2021

BUY
$53.75 - $76.55 $430 - $612
8 Added 16.0%
58 $3,000
Q2 2021

Jul 08, 2021

SELL
$59.02 - $78.8 $2,419 - $3,230
-41 Reduced 45.05%
50 $3,000
Q1 2021

Jun 17, 2021

SELL
$64.61 - $113.09 $3,230 - $5,654
-50 Reduced 35.46%
91 $6,000
Q4 2020

May 19, 2021

BUY
$48.06 - $84.4 $6,776 - $11,900
141 New
141 $10,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.32B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.